Atlas Trials

Safety and Tolerability of MSI-1436C in Metastatic Breast Cancer

Clinical trial NCT02524951 · TERMINATED

Trial details

NCT number
NCT02524951
Sponsor
Northwell Health
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Metastatic Breast Cancer
Start date
2016-04-01
Primary completion
2017-07-01
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.